Neutral endopeptidase and angiotensin-converting enzyme - Key enzymes terminating the action of neuroendocrine mediators

Experimental Dermatology, Supplement

Volumn 13, Issue 4, 2004, Pages 22-26

  Scholzen, Thomas E ^a   Luger, Thomas A ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Allergic contact dermatitis; Angiotensin converting enzyme; Neuroimmunology; Neutral endopeptidase; Skin

Indexed keywords

ALPHA INTERMEDIN; AUTACOID; BRADYKININ; BRADYKININ B2 RECEPTOR; CORTICOTROPIN; DIPEPTIDYL CARBOXYPEPTIDASE; GROWTH FACTOR; MEMBRANE METALLOENDOPEPTIDASE; METALLOPROTEINASE; NEUROHORMONE; NEUROKININ 1 RECEPTOR; SUBSTANCE P; ZINC;

ARTICLE; AUTOCRINE EFFECT; BIOAVAILABILITY; CELL SURVIVAL; DATA ANALYSIS; DENDRITIC CELL; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REGULATION; EPIDERMIS CELL; GENE DELETION; HUMAN; IMMUNOCOMPETENT CELL; IN VITRO STUDY; IN VIVO STUDY; MEDIATOR; MEDIATOR RELEASE; NEUROENDOCRINE SYSTEM; NOCICEPTIVE STIMULATION; NONHUMAN; PARACRINE SIGNALING; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PSORIASIS; SENSITIZATION; SENSORY NERVE; SKIN ALLERGY; SKIN CELL; SKIN DISEASE; SKIN INFLAMMATION; SKIN INJURY; SKIN PIGMENTATION; STIMULUS RESPONSE; T LYMPHOCYTE; TISSUE REGENERATION; ULTRAVIOLET RADIATION; WOUND HEALING;

EID: 10644263599     PISSN: 14791250     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-0625.2004.00260.x     Document Type: Article

References (35)

1. Scholzen T, Armstrong C A, Bunnett N W, Luger T A, Olerud J E, Ansel J C. Neuropeptides in the skin: interactions between the neuroendocrine and the skin immune systems. Exp Dermatol 1998: 7: 81-96.
2. Seeliger S, Derian C K, Vergnolle N et al. Proinflammatory role of proteinase-activated receptor-2 in humans and mice during cutaneous inflammation in vivo. FASEB J 2003: 17: 1871-1885.
3. Castro M G, Morrison E. Post-translational processing of proopiomelanocortin in the pituitary and in the brain. Crit Rev Neurobiol 1997: 11: 35-57.
4. Slominski A, Wortsman J, Luger T A, Paus R, Solomon S G. Corticotropin releasing hormone and proopiomelanocortin involvement in the cutaneous response to stress. Physiol Rev 2000: 80: 979-1020.
5. Turner A J. Exploring the structure and function of zinc metallopeptidases: old enzymes and new discoveries. Biochem Soc Trans 2003: 31: 723-727.
6. Turner A J, Hooper N M. The angiotensin-converting enzyme gene family: genomics and pharmacology. Trends Pharmacol Sci 2002: 23: 177-183.
7. Nadel J A. Peptidase modulation of neurogenic inflammation. In: Geppetti P, Holzer P, eds. Neurogenic Inflammation. Boca Raton: CRC Press Inc, 1996:115-127.
8. Olerud J E, Usui M L, Seckin D et al. Neutral endopeptidase expression and distribution in human skin and wounds. J Invest Dermatol 1999: 112: 873-881.
9. Toyoda M, Makino T, Kagoura M, Morohashi M. Expression of neuropeptide-degrading enzymes in alopecia areata: an immunohistochemical study. Br J Dermatol 2001: 144: 46-54.
10. Toyoda M, Morohashi M. New aspects in acne inflammation. Dermatology 2003: 206: 17-23.
11. Paus R, Heinzelmann T, Schultz K D, Furkert J, Fechner K, Czarnetzki B M. Hair growth induction by substance P. Lab Invest 1994: 71: 134-140.
12. Cole J M, Xiao H, Adams J W, Disher K M, Zhao H, Bernstein K E. New approaches to genetic manipulation of mice: tissue-specific expression of ACE. Am J Physiol 2003: 284: F599-F607.
13. Campbell D J. Vasopeptidase inhibition: a double-edged sword? Hypertension 2003: 41: 383-389.
14. Steckelings U M, Artuc M, Wollschlager T, Wiehstutz S, Henz B M. Angiotensin-converting enzyme inhibitors as inducers of adverse cutaneous reactions. Acta Derm Venereol 2001: 81: 321-325.
15. Baluk P, Thurston G, Murphy T J, Bunnett N W, McDonald D M. Neurogenic plasma leakage in mouse airways. Br J Pharmacol 1999: 126: 522-528.
16. Sulpizio A C, Pullen M A, Edwards R M, Brooks D P. The effect of acute angiotensin-converting enzyme and neutral endopeptidase 24.11 inhibition on plasma extravasation in the rat. J Pharmacol Exp Ther 2004: 309: 1141-1147.
17. Rosenqvist U, Persson K, Lindgren B R, Andersson R G. Effects of cilazaprilat and enalaprilat on experimental dermatitis in guinea pigs. Pharmacol Toxicol 1991: 68:404-407.
18. Rubinstein I, Iwamoto I, Ueki I F, Borson D B, Nadel J A. Recombinant neutral endopeptidase attenuates substance P-induced plasma extravasation in the guinea pig skin. Int Arch Allergy Appl Immunol 1990: 91: 232-238.
19. Lu B, Gerard N P, Kolakowski L F Jr et al. Neutral endopeptidase modulation of septic shock. J Exp Med 1995: 181: 2271-2275.
20. Sturiale S, Barbara G, Qui B et al. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading SP. Proc Natl Acad Sci USA 1999: 96: 11 653 -11 658.
21. Di Maria G U, Bellofiore S, Geppetti P. Regulation of airway neurogenic inflammation by neutral endopeptidase. Eur Respir J 1998: 12: 1454-1462,
22. Scholzen T E, Steinhoff M, Bonaccorsi P et al. Neutral endopeptidase terminates substance P-induced inflammation in allergic contact dermatitis. J Immunol 2001: 166:1285-1291.
23. Scholzen T E, Stander S, Riemann H, Brzoska T, Luger T A. Modulation of cutaneous inflammation by angiotensin-converting enzyme. J Immunol 2003: 170: 3866-3873.
24. Scholzen T E, Steinhoff M, Sindrilaru A et al. Cutaneous allergic contact dermatitis responses are diminished in mice deficient in neurokinin 1 receptors and augmented by neurokinin 2 receptor blockage. FASEB J 2004: 18: 1007-1009.
25. Emanueli C, Grady E F, Madeddu P et al. Acute ACE inhibition causes plasma extravasation in mice that is mediated by bradykinin and substance P. Hypertension 1998: 31: 1299-1304.
26. Niizeki H, Kurimoto I, Streilein J W. A substance P agonist acts as an adjuvant to promote hapten-specific skin immunity. J Invest Dermatol 1999: 112: 437-442.
27. Lambrecht B N. Immunologists getting nervous: neuropeptides, dendritic cells and T cell activation. Respir Res 2001: 2: 133-138.
28. Greco S J, Corcoran K E, Cho K J, Rameshwar P. Tachykinins in the emerging immune system: relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells. Front Biosci 2004: 9: 1782-1793.
29. Scholzen T E, Brzoska T, Fastrich M et al. Genomic deletion of neutral endopeptidase in mice promotes hapten uptake, maturation and function of bone marrow-derived dendritic cells. J Invest Dermatol 2002: 119: 308. (Abstract.)
30. Scholzen T E, Kalden D-H, Brzoska T et al. Expression of proopiomelanocortin peptides in human dermal microvascular endothelial cells: evidence for a regulation by ultraviolet light and interleukin-1. J Invest Dermatol 2000: 115: 1021-1028.
31. Scholzen T E, Grundmann S, Fastrich M, Brzoska T, Luger T A. Angiotensin converting enzyme is regulated in human dermal microvascular endothelial cells by ultraviolet irradiation, cytokines and sensory neuropeptides. Arch Dermatol 2004: 295: 387. (Abstract.)
32. Scholzen T E, Koenig S, Fastrich M, Luger T A. Processing of proopiomelanocortin peptides by dermal microvascular endothelial cell extracellular peptidases: implication for endothelial cell biologic functions and skin inflammation. J Invest Dermatol 2004: 122: A3.
33. Chan J, Smoller B R, Raychauduri S P, Jiang W Y, Farber E M. Intraepidermal nerve fiber expression of calcitonin gene-related peptide, vasoactive intestinal peptide and substance P in psoriasis. Arch Dermatol Res 1997: 289: 611-616.
34. Kikwai L, Babu R J, Kanikkannan N, Singh M. Preformulation stability of Spantide II, a promising topical anti-inflammatory agent for the treatment of psoriasis and contact dermatitis. J Pharm Pharmacol 2004: 56: 19-25.
35. Spenny M L, Muangman P, Sullivan S R et al. Neutral endopeptidase inhibition in diabetic wound repair. Wound Repair Regeneration 2002: 10: 295-301.